Journal of medicinal chemistry

Using data analysis of sulfur and fluorine in medicines to find new drug design opportunities

Updated

Abstract

A total of 1969 drugs were analyzed to explore the role of sulfur and fluorine in pharmaceuticals over the past 50 years.

  • Sulfur and fluorine are significant components in the composition of pharmaceuticals.
  • Trends were examined across 12 disease categories using a graphical montage of drug information.
  • The analysis highlights the structural diversity and evolution of sulfur in drug development.
  • Fluorine has been increasingly integrated into pharmaceuticals during the last five decades.
  • The findings aim to inspire new ideas in the field of drug development.

Simplified

Full Text

Full text is available at the source.

what lands in your inbox each week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free